GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » PB Ratio

Microbot Medical (FRA:CY9D) PB Ratio : 2.48 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Microbot Medical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-06), Microbot Medical's share price is €0.979. Microbot Medical's Book Value per Share for the quarter that ended in Mar. 2024 was €0.39. Hence, Microbot Medical's PB Ratio of today is 2.48.

The historical rank and industry rank for Microbot Medical's PB Ratio or its related term are showing as below:

FRA:CY9D' s PB Ratio Range Over the Past 10 Years
Min: 2.66   Med: 7.52   Max: 17.94
Current: 2.66

During the past 13 years, Microbot Medical's highest PB Ratio was 17.94. The lowest was 2.66. And the median was 7.52.

FRA:CY9D's PB Ratio is ranked worse than
57.12% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 2.28 vs FRA:CY9D: 2.66

During the past 12 months, Microbot Medical's average Book Value Per Share Growth Rate was -28.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -51.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Microbot Medical was 66.10% per year. The lowest was -87.00% per year. And the median was -18.10% per year.

Back to Basics: PB Ratio


Microbot Medical PB Ratio Historical Data

The historical data trend for Microbot Medical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical PB Ratio Chart

Microbot Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.43 1.97 4.02 3.29 4.79

Microbot Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 3.32 2.09 4.79 2.64

Competitive Comparison of Microbot Medical's PB Ratio

For the Medical Instruments & Supplies subindustry, Microbot Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Microbot Medical's PB Ratio falls into.



Microbot Medical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Microbot Medical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=0.979/0.394
=2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Microbot Medical  (FRA:CY9D) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Microbot Medical PB Ratio Related Terms

Thank you for viewing the detailed overview of Microbot Medical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical (FRA:CY9D) Business Description

Traded in Other Exchanges
Address
25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical (FRA:CY9D) Headlines

No Headlines